P1125: CELESTIMO: A PHASE III TRIAL EVALUATING THE EFFICACY AND SAFETY OF MOSUNETUZUMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA

Detalles Bibliográficos
Autores principales: Nastoupil, L., Morschhauser, F., Scholz, C. W., Bishton, M., Yoon, S.-S., Giri, P., Wei, M. C., Knapp, A., Li, C.-C., Bottos, A., Li, H., Purev, E., Bartlett, N. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430742/
http://dx.doi.org/10.1097/01.HS9.0000847368.92731.fb

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430742/
http://dx.doi.org/10.1097/01.HS9.0000847368.92731.fb

Ejemplares similares